Mycophenolate Mofetil 250 mg

Mycophenolate mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Sanis Health Inc. in Canada.

Mycophenolate mofetil is primarily used to prevent rejection in organ transplant patients. It works by suppressing the immune system to help the body accept the transplanted organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. Patients may wonder, 'What is mycophenolate mofetil used for?' It is specifically designed to support transplant patients by reducing the risk of organ rejection.

Common effects of mycophenolate mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some patients might experience fatigue or headaches. It is important to monitor for any unusual symptoms and consult a healthcare provider if severe side effects occur.

Mycophenolate mofetil should be handled with care, as it can increase the risk of infections and certain types of cancer. Patients should avoid activities that may increase the risk of injury or infection. Regular blood tests may be required to monitor blood cell counts and liver function. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Mycophenolate mofetil may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it may increase the risk of side effects.